Physician profile
Brian C Howse
NPI 1669454260
$2,066.71
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,294 · 2020: $212 · 2021: $351 · 2022: $193 · 2023: $16.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,063.84 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $170.37 | 2019 | |
| Merck Sharp & Dohme LLC | $111.98 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.19 | 2019 | |
| Abbvie INC. | $84.22 | 2019-2021 | |
| Lilly USA, LLC | $64.92 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.53 | 2019 | |
| Janssen Pharmaceuticals, INC | $58.71 | 2019 | |
| Eisai INC. | $58.23 | 2019 | |
| Aytu Biopharma, INC. | $37.18 | 2019 | |
| Glaxosmithkline, LLC. | $36.54 | 2019 | |
| Amgen INC. | $31.00 | 2019 | |
| Amarin Pharma, INC. | $28.15 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.09 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $20.70 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18.83 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.00 | 2019 | |
| Pfizer INC. | $16.36 | 2023 | |
| Ironshore Pharmaceuticals INC. | $14.06 | 2019 | |
| Ironwood Pharmaceuticals, INC | $11.84 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.69 | 2019 | |
| Circassia INC. | $11.32 | 2019 | |
| Sanofi-Aventis U.S. LLC | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Howse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.